Japan Pharma Manufacturers Association partners with Medidata

 01-Sep-15, BioSpectrum

Medidata, a provider of cloud-based solutions for clinical research, has collaborated with Japan Pharmaceutical Manufacturers Association (JPMA) to provide cloud-based technology for streamlining clinical trial costs across Japan by focusing on the consistent budgeting of trial sites.

Image: BioSpectrum

"As the Japanese clinical trial landscape evolves, it is increasingly important that we ensure consistent and fair payment-both for sponsors and sites," said Mr Shingo Haseto, taskforce leader, clinical evaluation expert committee, JPMA. "We're pleased to be collaborating with Medidata to better understand cost discrepancies and are confident that our research findings will lead to increased transparency around clinical trial costs related to site performance and, in doing so, ultimately improve the drug development process."

 Read the full article  

 Insights